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Introduction
Granular cell tumor
Granular cell tumor (GCT), also known as Abrikossoff tumor, 
is an uncommon soft tissue neoplasm that is generally benign. 
The tumor mostly presents in women and in dark-skinned 
individuals. Granular cell tumor rarely affects children,1,2 
although this tumor can develop at any age.1–3 Granular cell 
tumor is mostly known to appear in the oral cavity but can 
also be present in other sites of the body. Most cases of GCT 
are benign, with malignancy occurring in less than 1% to 2% 
of cases.4 Currently, there are no medicinal treatments for 
GCT and the only option is surgical excision.3,5 Necessity of 
excision is based on histological analysis of the tumor. Thus, a 
biopsy must be performed to correctly evaluate the morphol-
ogy and extension of the tumor.2 Hematoxylin-eosin (H&E) 
staining and immunohistological staining are commonly used 
to assess the tumor. Histologically, the tumorous lesion con-
sists of well-demarcated dermal proliferation of polygonal or 
circular cells with a small centrally located nucleus and granu-
lar eosinophilic cytoplasm. The characteristic wide cytoplas-
mic granules are named pustulo-ovoid bodies. The granules 
are PAS (Periodic Acid-Schiff ) positive; however, they are 
diastasis resistant. The epithelium that covers the tumor 
shows pseudoepitheliomatous hyperplasia. This feature of 
the tumor mandates inclusion of squamous cell carcinoma in 
the differential diagnosis. Complications with biopsies are 
rare, but possible complications include pain, local bleeding, 
local bruising, infection, allergic reaction to the medicine 
used in the procedure, or damage to the structures beneath 
the biopsy site.6
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ABSTRACT 
BACKGROUND: Granular cell tumor (GCT) is a relatively uncommon tumor that may affect the skin. The tumor can develop anywhere on 
the body, although it is predominately seen in oral cavities and in the head and neck regions. Here, we present the results of optical coher-
ence tomography (OCT) imaging of a large GCT located on the abdomen of a patient. We also present an analytical method to differentiate 
between healthy tissue and GCT tissues.
MATERIALS AND METHODS: A multibeam, Fourier domain, swept source OCT was used for imaging. The OCT had a central wavelength 
of 1305 ± 15 nm and lateral and axial resolutions of 7.5 and 10 µm, respectively. Qualitative and quantitative analyses of the tumor and healthy 
skin are reported.
RESULTS: Abrupt changes in architectures of the dermal and epidermal layers in the GCT lesion were observed. These architectural 
changes were not observed in healthy skin.
DISCUSSION: To quantitatively differentiate healthy skin from tumor regions, an optical attenuation coefficient analysis based on single-
scattering formulation was performed. The methodology introduced here could have the capability to delineate boundaries of a tumor prior 
to surgical excision.
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Optical coherence tomography of GCT
The technology currently available to physicians has remarka-
bly changed the way skin lesions can be evaluated.7 Certainly, 
the advancement of imaging modalities in the past 35 years has 
allowed physicians to detect skin abnormalities more precisely 
at earlier stages. To that end, GCTs have been imaged using 
computed tomography, magnetic resonance imaging, and posi-
tron emission tomography.8–11 Considering light as a form of 
electromagnetic radiation, its spectrum extends from low-
energy waves with long wavelengths to high-energy waves with 
short wavelengths. Because of light’s unique energy levels, each 
region interacts with tissue compartments differently. 
Ultraviolet, visible, and near-infrared optical imaging tech-
niques are potentially sensitive to pathophysiological and mor-
phologic changes in skin disease and may provide a noninvasive, 
nonionizing method of diagnosis. Optical imaging systems are 
based on the interactions of light with the tissue compart-
ments. They measure the optical properties of the tissue, such 
as the absorption coefficient, the scattering coefficient, and the 
anisotropy factor. The most important events that govern light 
and tissue interaction (Figure 1) include diffuse scattering, 
specular scattering, absorption, and fluorescence.7 In diffuse 
scattering, incident photons undergo multiple scattering at dif-
ferent refractive indices of biological compartments in the tis-
sue before they are absorbed. Specular scattering occurs when 
light is reflected with the same incident angle relative to the 
normal orientation. Absorption of light is caused by biological 
chromophores and fluorophores, where the energy absorbed 
may result in heat or luminescent emission from the tissue. 
Fluorescence is the most prominent form of luminescence, 
where energy is reemitted as light. The optical properties of 
biological tissue can be considerably altered during carcinogen-
esis and neoplastic tissue progression due to changes affecting 
endogenous chromophores, blood content, and tissue oxygena-
tion that alter light absorption and scattering.7,12,13 This is the 
principle of optical differential diagnosis imaging.
Optical coherence tomography (OCT) is an emerging 
imaging modality that is capable of acquiring high-resolution 
cross-sectional images of a tissue.14,15 Optical coherence 
tomography is a similar modality to ultrasound; however, infra-
red waves are used instead of sound waves. Compared with the 
existing optical imaging methods, such as confocal microscopy, 
OCT provides high-resolution images with a large penetration 
depth (>1.5 mm).14 Optical coherence tomography relies on a 
low-coherent light source and interferometry.14,16,17 The most 
basic OCT scheme is a time domain OCT in which a 
Michelson interferometer is used.14 The amplitude of electro-
magnetic radiation in this interferometer is divided into 2 parts 
by a beam splitter: E tref ( )  as the electromagnetic field of the 
light beam directed into a reference mirror and E tsamp ( )  as the 
one illuminated by the sample and is back-reflected by its 
structural elements which is a superposition of waves arriving 
with different delays. The more advanced scheme of OCT is 
Fourier domain OCT (FD-OCT). There are 2 ways for devel-
oping FD-OCT. The first one is called spectral (spectral 
domain) OCT, in which the detection of the interferometric 
signal is made by a spectrometer equipped with a high-speed 
line scan detector, eg, a charge-coupled device or complemen-
tary metal oxide semiconductor.18–22 The second one is called 
swept source OCT (SS-OCT), which uses high-speed tunable 
lasers.22–30 In SS-OCT, the spectral interferogram can be 
described in terms of wavenumber k  as31 follows:
Figure 1. Interaction of light with tissue compartments. Here, we demonstrate 4 events that can occur including diffuse scattering, specular scattering, 
absorption, and lorescence.
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where G k( )  is the intensity spectrum of the light, p  is the 
backscattering coefficient, z  is measured from the origin of 
coordinates in the sample arm (ie, at sample reference), p z( )  is 
the backscattering coefficient distribution, k  is the wavenum-
ber, and n ks ( )  is the refractive index of the sample. The final 
retrieved signal detected in SS-OCT is expressed as31 follows:
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where V k  is the line width and Gk  is the tuning mode-hop 
for compensation of changes in cavity length. The axial reso-
lution in OCT is determined by the coherence time or the 
coherence length ∆l of the light source and can be expressed 
by equation (3):
  ∆
∆
l
FWHM
=
2 2 0
2
ln
pi
λ
λ
 (3)
where O0  describes the central wavelength, and ∆λFWHM  is the 
full width at half-maximum of the spectral profile. Similar to the 
confocal microscopy, the transversal resolution in OCT is deter-
mined by the size of the focused spot of the scanning beam.32
Optical coherence tomography, with an intermediate 
resolution (<10 µm) and penetration depth (~1.5-2 mm), has 
become a popular diagnostic-assistant imaging modality in 
dermatology in the past decade. Tissue contrast in OCT 
images is generated by the intrinsic scattering characteristics 
of tissues which are proportional to the density, size, and shape 
of the tissue microstructures. Because tumor cells have a dif-
ferent refractive indices and absorption characteristics than 
normal cells, OCT images are expected to discriminate tumor 
tissues from normal tissues and benign neoplasms. Such a dif-
ferentiation can be difficult to determine as it is based solely 
on the tissue microstructures visualized in the OCT image. 
Several groups, including us, have studied OCT image 
enhancement as well as texture analysis of OCT images to 
improve skin cancer detection; however, the resultant specific-
ity was still low—around 80%. It is our belief that the specific-
ity of OCT imaging used to differentiate tumor tissue from 
healthy skin could be improved using the quantitative analysis 
of OCT images.
Methodology
OCT system configuration
The OCT system used in this study is an SS-OCT from 
Michelson Diagnostic. This system functions using a tunable 
laser source with the confined central wavelength of 1305 nm 
and a laser wavelength sweep range of 150 nm. This system is 
based on a multibeam technology, similar to dynamic focus 
technology,33 using a scheme involving 4 consecutive confocal 
gates each of approximately 0.25 mm width. Using the multi-
beam technology, the images obtained from the 4 channels 
are averaged. In the SS-OCT, the reflectivity profile is termed 
as an axial scan (A-scan or A-line). By grouping together sev-
eral A-lines for different transversal positions of the incident 
beam on the sample, a cross-sectional image or a B-scan is 
generated.17 C-scan depicts the object’s top view that can be 
at a specific depth. The images obtained with this OCT sys-
tem are B-scan images with a size of 6 mm × 2 mm and soft-
ware-inferred en face images with a size of 6 mm × 6 mm. In 
the OCT system, the lateral resolution is measured as 7.5 µm 
and the axial resolution is measured as 10 µm. The penetra-
tion depth of our OCT system is about 2 mm. In Figure 2, a 
typical OCT image of healthy skin from the dorsal hand of a 
volunteer is presented.
Figure 2. A typical optical coherence tomography image of the dorsal hand skin. The multiple layers of the skin (stratum corneum, epidermis, and 
dermis) are clearly visible and are labeled. The scale of the image has been modiied to match the size of the page.
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The appearance of the skin with OCT is determined by its 
optical properties. Cellular structures within the tissue affect 
the absorbance and scatting of light, both of which affect the 
reflectance and attenuation of light.34 Understanding the 
appearance of healthy skin on OCT is necessary to identify 
morphological changes in diseased skin.19 In healthy skin, the 
stratum corneum is a low-absorbing medium and appears as a 
highly reflective region on the OCT B-scan.35 The epidermis 
and dermis appear as relatively lower reflective regions as they 
propagate, absorb, and scatter light.36 The events in the epider-
mis are a result of the melanin content and in the dermis are 
mainly due to collagen fibers.36 The epidermis-dermis junction 
is quite visible and is readily distinguishable by the lower con-
trast area in between the two. The dermis visibly extends from 
the junction to where a signal no longer exists. Other structures 
in skin, such as blood vessels, hair follicles, and hair bulbs, can 
be identified as hyporeflective regions.35 The OCT image pix-
els show the forms of the skin’s microstructure based on their 
size, refractive index, and shape.
Attenuation coeff icient analysis
Due to the scattering and absorbing structures, light is attenu-
ated when it travels within a tissue.37 Beer-Lambert law, which 
is governed by exponential decay, can help explain this attenu-
ation using the single-scattering model of the skin (equation 
(4)). Attenuation coefficient can be considered the method of 
choice because of its successful use in characterizing tissue in 
the literature.16–18,38 Characterization of the tissue can conse-
quently provide information about structural changes in the 
tissue. Recently, Vermeer et al17 developed a simple method to 
estimate the attenuation coefficients locally where every pixel 
in the OCT data set is converted into a corresponding optical 
absorption coefficient (OAC) pixel. This produces accurate 
results for both homogeneous and heterogeneous tissues and 
does not require presegmenting or preaveraging of data. The 
attenuation coefficient analysis method was evaluated as a 
diagnostic tool. The single-scattering equation is determined 
as follows:
I x I e x( ) = −0 2ρ µ  (4)
where I  represents the value of the detected intensity, I0  is 
the intensity of incident light, U  is the backscattering coef-
ficient, µ is the attenuation coefficient, and x  is the depth. 
The factor of 2 comes from the fact that light travels round 
trip within the tissue. The common way to calculate an atten-
uation coefficient is by fitting an exponential curve to the 
above equation (equation (4)), on which the decay constant 
can be extracted. The resulted values are then averaged, 
smoothened, and fitted into a polynomial equation. The slope 
of the equation thus yields an attenuation coefficient of the 
region. This method of analysis was applied in this study, as 
outlined in Figure 3. An attenuation coefficient calculator 
was implemented in MATLAB following the backscattering 
equation (equation (4)) for all the regions. A single-dimen-
sional normalized histogram was computed using all attenu-
ation coefficients in the images and regions for healthy and 
GCT skin. Descriptive analysis was performed for the distri-
bution of attenuation coefficients. All data processing was 
performed using R (version 3.3.2, 2016, The R Foundation 
for Statistical Computing).
Patient imaging
All imaging procedures and experimental protocols were 
approved and conducted in accordance with the guidelines 
stipulated by the US National Institutes of Health. Approval to 
conduct the experiment was obtained from Wayne State 
University’s Institutional Review Board and an informed con-
sent was secured from all subjects before enrollment in the 
study. Images of skin conditions were collected in Wayne State 
University.
An African American woman (dark-skinned) of age 25 pre-
sented with a skin-colored papulonodule with overlying hyper-
keratosis in the left iliac area (Figure 4B and C). The red dots 
in Figure 4B represented the imaging sites on GCT lesion, and 
the red circle with “H” represented the imaging sites on healthy 
skin. The lesion was approximately 7 cm in length and 5 cm in 
width. The patient showed no sign of pain unless pressure was 
applied, especially on the lower border of the lesion.
Our goal was to image the lesion and surrounding healthy 
tissue and then compare the image with histological data. The 
areas of interest were scanned from top to bottom and left to 
right covering all the lesions and some of the surrounding skin. 
Healthy skin from around the area, about 10 cm away from the 
lesion, was also imaged to be used later as the “healthy skin 
reference” during analysis. The probe moved vertically while 
the scanning beam traveled horizontally and orthogonally to 
the direction of the probe’s movement.
Results
Patient imaging
In total, 27 areas were imaged on the patient. Each scanned 
area yielded an image stack with 170 tomographic B-scan 
images from the OCT that could be used for analysis and 
interpretation. Figure 5A and B shows some of the OCT 
images selected for the attenuation coefficient calculation, and 
Figure 5C is an OCT image of the healthy tissue near the 
lesion site for comparison. The OCT images of the GCT dem-
onstrate verrucous epidermal hyperplasia, seen as the hyperre-
flective, uneven surface of the tissue. The dermo-epidermal 
junction is obscured in the OCT images of GCT while it is 
discernible in the adjacent healthy skin. Blood vessels can be 
seen in the dermis of healthy skin but not in the images of 
GCT. For the area of healthy and the area of diseased tissue, 
163 regions from B-scan images were selected for calculation 
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of the attenuation coefficient. Within each B-scan image, mul-
tiple regions of interest with different dimensions and locations 
were determined randomly, as outlined in Figure 3A. Each 
region of interest is outlined in brown (Figure 3A).
In total, 163 regions of interest from B-scan images were 
analyzed: 82 regions were analyzed from a total of 9 different 
GCT area images and 81 regions from 7 different healthy skin 
area images. The summary of this data analysis can be found in 
Figure 6. The comparison between the attenuation coefficients 
of GCT and healthy tissue reveals a quantifiable difference in 
the skin. As demonstrated in Figure 6, the attenuation coeffi-
cients in GCT are on average much higher but with similar 
variation compared with healthy skin. The average attenuation 
coefficient for GCT was −0.00139 with a standard deviation of 
0.00043. In healthy skin, the average value was −0.00217 with 
a standard deviation of 0.000485. This indicates a lower 
Figure 3. Attenuation coeficient calculation in OCT images: (A) regions of interest in an OCT image, (B and C) one enlarged region of interest 
determined in (A) and outlined in brown. (D) Plots from the enlarged region of interest in (B): the average of 100+ A-lines, smoothed average A-line, and 
the polynomial linear line that is itted to them. In (D), the OCT signal axis has been normalized, and the depth is represented relative to the true scale of 
the OCT image in (A). OCT indicates optical coherence tomography.
Figure 4. Photograph showing the GCT lesion in the left iliac region with some healthy regions around it. Photograph of the (A) healthy region indicated 
in (B) with the black square in left, (B) GCT and some surrounding healthy regions, (C) a part of the GCT indicated in (B) with the right black square. Solid 
red dots in (B) are the imaging location on the lesion while circles with an “H” represent the healthy skin chosen as a reference. The scale bar is 23 mm. 
GCT indicates granular cell tumor.
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attenuation coefficient value for healthy skin, signifying a 
greater penetration depth for light into healthy skin. The 
median fitted polynomial equation for GCT was found to be 
y = −0.0014x + 0.288 and for healthy skin y = −0.0022x + 0.444. 
In healthy skin, the slope is steeper compared with GCT, but 
the value appeared to attenuate from a much higher OCT sig-
nal value. In GCT, the intercept value of the fitted equation is 
much lower, suggesting that the region is already hypodense or 
has lower OCT signal intensity due to attenuation.
GCT histology
Granular cell tumors are composed of sheets of large polyhe-
dral cells, irregularly arranged, containing a hyperchromatic 
nucleus and abundant cytoplasm that is fine to coarsely granu-
lar. The nuclei are small and round and each can contain either 
1 or 2 nucleoli. Basal lamina surrounds the tumor cells and 
elastosis in the stroma of the tumors is common. The cyto-
plasm is abundant in granules, typically phagolysosomes, of 
varying shapes and sizes, and the cytoplasmic borders are not 
always well defined.39 Granular cell tumors can contain S-100 
protein, neuron-specific enolase, PGP9.5, and NKI/C-3. The 
cells are positive for esterase and acid phosphatase.39 Well-
defined criteria to differentiate benign and malignant tumors 
do not exist. However, size larger than 5 cm, rapid growth, 
vascular invasion, and necrosis can all be indicative of 
malignancy.39 CD34 is the hematopoietic progenitor cell anti-
gen, and stains to detect this can reveal the growth of vascular 
structures or blood vessel invasion referred, which can signify 
Figure 6. Density plot of attenuation coeficients calculated for healthy 
skin and GCT. GCT indicates granular cell tumor.
Figure 5. OCT images of (A and B) GCT lesion, and (C) healthy skin. Irregularity of epidermis (A and B) caused by verrucous seborrheic keratosis lying 
on top of the GCT lesion. GCT indicates granular cell tumor; OCT, optical coherence tomography.
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potential malignancy.39,40 Our patient’s biopsy demonstrated 
many characteristics typical of GCT. The H&E-stained sam-
ples and S-100 immunohistological stained samples can be 
seen in Figure 7. The dermis contains a proliferation of cells 
with abundant cytoplasm with tiny eosinophilic cytoplasmic 
granules as well as a perivascular lymphocytic infiltrate. The 
S-100 immunohistochemical stain demonstrates cytoplasmic 
and nuclear positivity (Figure 7C and D). This stain is indica-
tive of nerve sheath differentiation, adding support to the 
Schwann cell origins of GCT. The Factor XIIIa stain high-
lights a minority of the lesional cells. No features of malig-
nancy were found in the sections examined. There was no 
vascular invasion, necrosis, significant cytologic atypia, or sig-
nificant spindling present. The CD34 immunohistochemical 
stain is also negative in the lesional cells.
Discussion
In this study, we demonstrated a quantifiable relationship of 
the changes in tissue due to GCT and the effects on the optical 
properties of the skin on OCT imaging. Interpreting A-line 
scans from B-scan images revealed an increased attenuation 
coefficient in the GCT compared with normal skin (Figures 3 
and 6). The difference in attenuation coefficient reflects a 
change in the penetration depth of light, with a lower attenua-
tion coefficient representing deeper penetration of light in nor-
mal skin.41 The impedance of light penetration in GCT can be 
attributed to the presence of tumor cells in the dermis. Mourant 
et al42 previously determined that most of the scattering takes 
place due to light interactions with organelles within the cell 
and concluded that cell shape and size have little effect on scat-
tering properties. One such organelle that could possibly cause 
such significant effects is the nucleus. Because diseased cells 
divide more rapidly than healthy cells, they will contain greater 
amounts of nuclear proteins.43 In GCT, cytoplasmic borders 
are difficult to delineate and elastosis in the stroma of the 
tumors is common, resulting in alterations to the collagen fib-
ers normally present in healthy tissue. The histology images of 
GCT illustrate the abundance of nuclei that occupy the many 
irregularly arranged cells. The presence of cytoplasmic granules 
characteristic of GCT also seen in the histology images has an 
effect on optical properties of the lesion. Smaller organelles, 
such as lysosomes, have also been suggested to be a likely cause 
for scattering at large angles.42 The alteration to the extracel-
lular membrane between cells and the change in cell geometry 
may also contribute to the changes in the tissue’s optical 
properties.
Most of the absorption of light is attributed to the melanin 
in skin. Melanin is synthesized and punctated into the internal 
walls of melanosome, which is a 1-µm-diameter organelle.26 
The amount of melanin within melanosomes can have 10-fold 
variation. For light-skinned whites, the volume fraction of 
melanosomes is about 1% to 3%; for the darkly pigmented 
Africans, it is about 18% to 43%.44 Accordingly, attenuation 
coefficient of skin may also vary. The attenuation coefficient is 
about 0.028 mm−1 for a moderately pigmented adult with 10% 
volume fraction of melanosomes.45
Figure 7. Histological images of the granular cell tumor corresponding to the lesion depicted in Figure 3. (A) hematoxylin-eosin stain at ×100 
magniication, also outlining the region (B) at 400× magniication. The lesional cells containing abundant cytoplasm with tiny eosinophilic cytoplasmic 
granules and perivascular lymphocytic iniltrate is seen. (C) S-100 stain at ×100 magniication of the same sample, also outlining the region (D) at ×400 
magniication. The S-100 stain demonstrates cytoplasmic and nuclear positivity. The scale bar is 65 µm.
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One reason that different attenuation values are seen is due 
to the method of calculation of the attenuation coefficient as 
previously described. The averaged A-line values were based on 
subsurface scattering and ignored skin surface scattering that 
could alter results. In addition, of the random regions of inter-
est assessed, the 163 regions of interest chosen to use were 
those with uniform homogeneity of the OCT signal. In the 
healthy OCT images, there are more diverse regions of homo-
geneity to choose from in terms of signal intensity. Because of 
this, the detected signal intensities in the regions of interest for 
unhealthy skin have a lower range of values compared with 
those of healthy skin. Another observation suggests that the 
OCT signal of GCT attenuates more rapidly near the surface 
of the skin, as suggested by the surface hyperreflections, whereas 
the signal in healthy skin experiences gradual and increasing 
attenuation throughout the tissue layers. Granular cell tumor 
has a recurrence rate of 20% in benign tumors when the surgi-
cal margins are positive.1 In the future, OCT imaging of GCT 
could perhaps provide a novel way to accurately delineate 
tumor margins to plan surgical excision to prevent further 
GCT recurrence. Using OCT image enhancement meth-
ods,46–54 the OAC algorithm may be improved. Other emerg-
ing imaging modalities, eg, photoacoustic imaging, may also be 
combined with OCT to improve the diagnosis of GCT.50
Conclusions
A GCT lesion and its surrounding healthy skin were imaged 
using an SS-OCT. The optical attenuation coefficient analysis 
on the tumorous and healthy areas showed a quantifiable dif-
ference between their optical properties. This study demon-
strates that analysis of attenuation coefficient on OCT imaging 
can delineate abnormal skin, in this case, GCT and normal 
skin. Further study is necessary to determine whether attenua-
tion coefficient values correlate with specific skin abnormali-
ties, producing a means to objectively differentiate and diagnose 
various skin diseases with OCT. With the implementation of 
an OCT with a longer scanning range, it may be possible to 
image the border of large tumors. This could lead to more 
accurate delineation of tumor margins with which to plan sur-
gical excisions.
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